BCM
XLRN

BCK Capital Management’s Acceleron Pharma XLRN Stock Holding History

BCK Capital Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,000
Closed -$861K – 150
2021
Q3 		$861K Buy
+5,000
New +$654K 0.51% 47

BCK Capital Management's XLRN Position: Q4 2021 in Review

BCK Capital Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 5,000 shares — an estimated $861K sold.

BCK Capital Management first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $861K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • BCK Capital Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • BCK Capital Management sold 5,000 Acceleron Pharma shares in Q4 2021, an estimated $861K.
  • BCK Capital Management first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
  • BCK Capital Management's Acceleron Pharma position peaked at $861K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on BCK Capital Management's 13F filing for Q4 2021, filed 7 Feb 2022.